Articles From: 2014/12/8 - New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA® (Pembrolizumab) For Advanced Melanoma to 2014/12/8 - Advaxis Announces FDA Acceptance of Its Investigational New Drug Application to Commence Clinical Trials of ADXS-PSA in Combination With Merck's KEYTRUDA(R) (pembrolizumab) for Prostate Cancer


2014/12/8
Study is the First to Evaluate Investigational Combination of an Oncolytic Immunotherapy and Anti-PD-1 Therapy THOUSAND OAKS, Calif.
Sign-up for 2014/12/8 - New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA® (Pembrolizumab) For Advanced Melanoma investment picks
2014/12/8
F5 Networks, Inc. (NASDAQ: FFIV) today announced that company management will participate in the Barclays Global Technology Conference at The Palace Hotel, 2 New Montgomery Street, San Francisco, Calif.
Sign-up for 2014/12/8 - F5 Networks to Present at the Barclays Global Technology Conference investment picks
2014/12/8
http://media3.marketwire.com/logos/20120223-PROPH.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for 2014/12/8 - Prophecy Coal Announces $3,596,000 Private Placement With Strategic Asian Partner investment picks
2014/12/8
The price target on Apple's stock (AAPL) was raised to $135 from $120 by Citigroup analyst Jim Suva, which implies a 20% rally from current levels.
Sign-up for 2014/12/8 - Apple's new stock price target at Citigroup implies 20% rally investment picks
2014/12/8
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cubist Pharmaceuticals, Inc. (“Cubist” or the “Company”) (Nasdaq: CBST) relating to the proposed buyout of the Company by Merck & Co., Inc. (“Merck”). On December 8, 2014, Cubist and Merck announced the signing of a definitive agreement pursuant to which Merck will acquire Cubist in a transaction valued at approximately $9.5 billion.
Sign-up for 2014/12/8 - SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information investment picks
2014/12/8
Fans Inspire the Revival of the 1990's Favorite MINNEAPOLIS , Dec.
Sign-up for 2014/12/8 - French Toast Crunch Cereal Makes Slammin' Return investment picks
2014/12/8
Levi & Korsinsky is investigating the Board of Directors of Spansion, Inc. (“Spansion” or “the Company”) (NYSE: CODE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Cypress Semiconductor Corporation (“Cypress”) (NasdaqGS: CY). Click here to learn more about the investigation: http://zlk.9nl.com/spansion-code .
Sign-up for 2014/12/8 - INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Spansion, Inc. Regarding the Fairness of the Sale of the Company to Cypress Semiconductor Corp. -- CODE investment picks
2014/12/8
BEVERLY, Mass., Dec.
Sign-up for 2014/12/8 - Atlantic Tele-Network Board Increases Quarterly Dividend investment picks
2014/12/8
HARTSVILLE, S.C., Dec.
Sign-up for 2014/12/8 - Sonoco Receives WorldStar 2015 Packaging Award for Whirlpool(R) Water EveryDrop(TM) Water Filter Package investment picks
2014/12/8
SapientNitro , part of Sapient® (NASDAQ:SAPE), today announced that is has been named a leader in Forrester Research, Inc.’s December 2014 report: “The Forrester Wave™: Innovation Agencies, Q4 2014.” Forrester selected for participation in this Wave the 10 most significant agencies.
Sign-up for 2014/12/8 - SapientNitro Named an Innovation Agency Leader by Independent Research Firm investment picks
2014/12/8
B/E Aerospace, Inc. (“B/E Aerospace” or the “Company”) (NASDAQ:BEAV) announced today that its wholly-owned subsidiary KLX Inc. (“KLX”) has successfully closed its previously announced offering of $1.2 billion aggregate principal amount of 5.875% senior notes due 2022 (the “Notes”). The Notes were issued at 100% of the aggregate principal amount.
Sign-up for 2014/12/8 - B/E Aerospace Announces Closing of Offering of Senior Notes by KLX investment picks
2014/12/8
Forestar Group Inc. ("Forestar") (NYSE: FOR) today announced that its Board of Directors, working together with its management team and financial advisor, Goldman, Sachs & Co., is exploring strategic alternatives to enhance shareholder value.
Sign-up for 2014/12/8 - Forestar Announces Plan to Explore Strategic Alternatives to Enhance Shareholder Value investment picks
2014/12/8
Seattle Genetics, Inc. (Nasdaq: SGEN) today highlighted multiple ADCETRIS (brentuximab vedotin) data presentations in frontline and salvage Hodgkin lymphoma (HL) at the 56 th American Society of Hematology (ASH) Annual Meeting and Exposition taking place in San Francisco, CA, December 6-9, 2014.
Sign-up for 2014/12/8 - Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in Frontline and Salvage Hodgkin Lymphoma at ASH Annual Meeting investment picks
2014/12/8
http://www.ccnmatthews.com/logos/20051006-BMO170.jpg TORONTO, ONTARIO --
Sign-up for 2014/12/8 - BMO Financial Group Named a Top Employer for Ninth Consecutive Year investment picks
2014/12/8
Fiserv , Inc. (NASDAQ: FISV), a leading global provider of financial services technology solutions, announced today that Marc West has been named president of its Digital Channels business.
Sign-up for 2014/12/8 - Fiserv Names Marc West Division President, Digital Channels investment picks
2014/12/8
VANCOUVER , Dec.
Sign-up for 2014/12/8 - TAG Announces Share Buyback investment picks
2014/12/8
Top Semiconductor Companies Quickly Adopting IC Compiler II to Tapeout Across Range of Technology Nodes MOUNTAIN VIEW, Calif.
Sign-up for 2014/12/8 - Synopsys' Latest Release of IC Compiler II Ready for Broad Availability of the Power of 10X investment picks
2014/12/8
By Sue Chang, MarketWatch H&R Block is set to report after Monday's close NEW YORK (MarketWatch) -- These are the stocks set to make notable moves in the market Monday: Gainers Vail Resorts(MTN) delivered a narrower-than-expected loss and offered a fresh plan to build out its ski resorts.
Sign-up for 2014/12/8 - UPDATE: McDonald's rings up weak sales; Vail Resorts posts narrower loss investment picks
2014/12/8
Company Introduces New Antibiotic Analytics Dashboard at ASHP Midyear Clinical Meeting ORANGE COUNTY, Calif.
Sign-up for 2014/12/8 - Cardinal Health Launches New Analytics Tool To Help Hospitals Improve Antibiotic Stewardship Efforts investment picks
2014/12/8
CHATSWORTH, Calif., Dec.
Sign-up for 2014/12/8 - Capstone Turbine Secures 3MW Order to Upgrade State-of-the-Art Glasshouse in South Australia investment picks
2014/12/8
McDonald's Corp.
Sign-up for 2014/12/8 - McDonald's shares slide on weak Nov sales, profit warning investment picks
2014/12/8
SL Green Realty Corp.
Sign-up for 2014/12/8 - SL Green to Acquire Stake in Stonehenge’s New York City Residential Portfolio investment picks
2014/12/8
Aruba Networks, Inc. (NASDAQ:ARUN) today announced that NHS Human Services, a leader in community-based, behavioral healthcare, has replaced its Cisco wireless network with an Aruba wireless infrastructure.
Sign-up for 2014/12/8 - NHS Human Services Improves Clinician Productivity, Delivers Better Care With Aruba Wireless Infrastructure investment picks
2014/12/8
Analog Devices, Inc. (NASDAQ: ADI), a global leader in high-performance semiconductors for signal processing applications, announced today that its complete RF and microwave portfolio, including the Hittite Microwave Products from Analog Devices, is now available for sale through the company’s extensive distribution network.
Sign-up for 2014/12/8 - Hittite Microwave Products from Analog Devices Now Available Through ADI’s Worldwide Sales Distribution Network investment picks
2014/12/8
Booz Allen Hamilton Holding Corporation (NYSE:BAH), the parent company of management and technology consulting firm Booz Allen Hamilton, will host a conference call at 8 a.m. EST on Wednesday, January 28, 2015, to discuss the financial results for its Third Quarter of Fiscal Year 2015 (ending December 31, 2014). A news release containing the results will be issued before the call.
Sign-up for 2014/12/8 - Booz Allen Hamilton to Host Conference Call to Discuss Third Quarter Fiscal 2015 Results on Wednesday, January 28, 2015 investment picks
2014/12/8
OAK BROOK, Ill.
Sign-up for 2014/12/8 - McDonald's Reports Global Comparable Sales For November investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: 2014/12/8 - New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA® (Pembrolizumab) For Advanced Melanoma to 2014/12/8 - Advaxis Announces FDA Acceptance of Its Investigational New Drug Application to Commence Clinical Trials of ADXS-PSA in Combination With Merck's KEYTRUDA(R) (pembrolizumab) for Prostate Cancer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent